Formaat : 50mg
Synonyms:
| Description | PPARγ agonist12 (compound 9i) is a potent and selective PPARγ agonist, exhibiting EC50 values of 3.98 μM for PPARγ and 15.42 μM for PPARδ. It enhances insulin secretion and demonstrates antidiabetic properties. |
| In vivo | Administered at 36 mg/kg orally in a single dose, PPARγ agonist 12 demonstrates antidiabetic effects in NA-Streptozotocin-induced diabetic rats. |
| Formula | C25H23N3O6S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO stock solution to 400 µL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|
